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ABSTRACT A cultured rat ovarian cell line (31A-F2) was used to study the effect of growth
factors (epidermal growth factor [EGF] and fibroblast growth factor [FGF]), a survival factor
(ovarian growth factor [OGF]), a hormone (insulin), and an iron-binding protein (transferrin)
on cell proliferation and steroid production under defined culture conditions. EGF and insulin
were shown to be mitogenic (half-maximal response at 0.12 nM and 0.11 /AM, respectively) for
31A-F2 cells incubated in serum-free medium . EGF induced up to three doublings in the cell
population, whereas insulin induced an average of one cell population doubling. FGF, OGF,
and transferrin were found not to have any prominent effect on cell division when incubated
individually with 31A-F2 cells in serum-free medium. However, a combination of EGF, OGF,
insulin, and transferrin stimulated cell division to the same approximate extent as cells
incubated in the presence of 5% fetal calf serum.
EGF or insulin did not significantly affect total cell cholesterol levels (relative to cells
incubated in serum-free medium) when incubated individually with 31A-F2 cells. However,
cell cholesterol levels were increased by the addition of OGF (250%), FGF (370%), or a
combination of insulin and EGF (320%). Progesterone secretion from 31A-F2 cells was enhanced
by EGF (25%), FGF (80%), and insulin (115%) . However, the addition of a mitogenic mixture of
EGF, OGF, insulin, and transferrin suppressed progesterone secretion 150% below that of
control cultures. These studies have permitted us to determine that EGF and insulin are
mitogenic factors that are required for the growth of 31A-F2 cells and that OGF and transferrin
are positive cofactors that enhance growth . Also, additional data suggest that cholesterol and
progesterone production in 31A-F2 cells can be regulated by peptide growth factors and the
hormone insulin.
Mitogenicactivity oflow molecular weight proteins on cultured
cells has been reported for several cell lines (8). A major
drawback has been the requirement of a minimal amount of
serum to maintain theviability of thecellsand yet notso much
as to initiate multiple cell division. The question arises then as
to whether the addition of a growth factor in an assay system
is alone responsible for growth. Hayashiet al. (9) have reported
that a mixture of hormones can stimulate the growth of GH3
rat pituitary cells in the absence of serum. Wyche and Note-
boom (15) found that rat ovarian cells (31A-F2) maintained in
serum-free medium required the addition of a factor isolated
from fetal calf serum (FCS)' that could initiate and maintain
'Abbreviations usedin thispaper: EGF, epidermalgrowth factor; FCS,
fetal calf serum; FGF, fibroblast growth factor; OGF, ovarian growth
factor.
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continuous cell division. We have also reported that a growth
factor derived from serum-free conditioned medium in which
human pituitary cells have been cultured also stimulates 31A-
F2 cells in an analogous manner (16). We have suggested that
complex interactions may occur between isolated serum and
growth factors underdefinedcultureconditions (15). Recently,
we have demonstrated that 31A-F2 cells synthesize and secrete
sex steroids into the culture medium. This communication
presents further findings on the growth-promoting activities of
isolated growth factors and the hormone insulin on 31A-F2 cell
growth and steroid production.
sDawson, W. E., and J. H. Wyche. 1979. Identificationofsexsteroids
secreted by cultured rat ovarian cells in defined medium. Manuscript
submitted for publication.
483MATERIALS AND METHODS
Cell Culture
Experiments were performed with a rat ovarian epithelial subline (31A-F2)
which has been previously described (15). These cells have been grown continu-
ously for over three years in Coon's Modified Ham's F-12 Medium (Coon's
medium, obtained from Pacific Biological Co., Richmond, Calif) plus a factor
(15) isolated from FCS (obtained from Grand Island Biological Co., Grand
Island, N. Y.) and ovarian growth factor (OGF) (8) which was generously
supplied by Dr. Denis Gospodarowicz at the University of California, San
Francisco. The growth and handling of stock cells and the composition of the
medium have been described elsewhere (15). These cells have been periodically
checked for mycoplasma contamination (12) by autoradiography and found to
be mycoplasma-negative.
Growth Assays
Stock 31A-F.2 cells were detached from plastic dishes by trypsinization with
0.5 ml of a 0.01% sterile trypsin (American Biochemicals Co., Cleveland, Ohio)
solution within 5 min at 37°C. The activity of trypsin was inhibited with 0.5 ml
of a 5 mg/ml sterile solution of ovomucoid trypsin inhibitor (Sigma Chemical
Co., St. Louis, Mo.). The cells were spun down at 1,000 rpmfor 5 min, and the
cell pellet was washed once with 5-10 ml of fresh serum-free Coon's medium.
Thecell pellet was resuspended in fresh serum-free Coon's medium and plated
at a density of about 5 x 10° cells/60 x 15 mm culture dish (Corning Glass
Works, Science Products Div., Corning, N. Y.), each dish containing a total
volume of 5 ml of serum-free Coon's medium with or without additions. The
protein factors (insulin and transferrin, Sigma Chemical Co., St. Louis, Mo.;
OGF. epidermal growth factor [EGF], and fibroblast growth factor [FGF],
Collaborative Research Inc., Waltham, Mass.) assayed for growth were added as
indicated in the legends of figures. The cells were incubated at 37°C in an
incubator with a humidified atmosphere of 5% C02:95% air. At various times,
dishes were removed and the attached cells were washed then detached with 0.5
ml of a 0.01% trypsin solution. Thecells were resuspended with an additional 9.5
ml of a phosphate-buffered physiological saline solution and counted with a
Coulter counter in a range not to exceed 30,000 cells/0.5 ml.
Steroid Analyses
Stock 31 A-F: cells were prepared asoutlined above and plated at a density of
about 1.5 x IO''/75-cm' culture flask (Corning Glass Works) containing 10 ml of
serum-free medium. Cells were incubated without and with proteins (insulin,
EGF, FGF, insulin, OGF, transferrin) orother chemicals (epinephrine, N"-2'-O-
dibutyryl cyclic AMP[(Bu)2cAMP], N''-2'-O-dibutyryl cGMP[(Bu}2cGMP], ob-
tained from Sigma Chemical Co.) for 8 din a humidified CO, incubator. At the
end of the incubation period the medium was removed and extracted separately
with anhydrous ether and the extracted residue was reconstituted in methanol as
recently described.' The cells were washed once with cold serum-free medium
and then extracted with 30% potassium hydroxide at 90'C for 4 h. Thesolution
was then made 50% with respect to ethanol. The alcoholic mixture was then
extracted with 10 times the volume ofchloroform, evaporated todrynessat45°C.
and the residuewas washed five times with 10 ml ofdistilled water.Theremaining
residue was extracted with anhydrous ether, evaporated to dryness, and reconsti-
tuted in I ml of methanol. Both the cell and medium methanol mixtures were
stored at -40°C for total cholesterol and progesterone analyses, respectively.
The medium extracts were assayed by a modified specific radioimmunoassay
for progesterone (2, 14, and footnote 2) using [1,2,6,7,-''H(N)]progesterone (New
England Nuclear, Boston, Mass.) as tracer at 97.9 Ci/mmol stock specific activity.
Progesterone antiserum was obtained from Dr. R. E. Short at the USDA Range
Station, Miles City, Mont. The cell extracts were assayed for total cell cholesterol
by the method of Rudell and Morris (13) as modified from the Zlatkis and Zak
(18) procedure. The standard curve used re-crystallized cholesterol (generously
supplied by Dr. J. L. Gaylor, University of Missouri) as the standard and was
linear from 2.5 to 20 ug. Data from progesterone and cholesterol assays were
analyzed by the Student's t test for significance.
RESULTS
Effect of EGF, FGF, and OGF with and without
Serum on 31A-F2 Cell Growth
Cultured 31A-F2 rat ovarian cells were found to be very
sensitive to factors present in low concentrations in FCS. When
the cells were incubated with serum concentrations ranging
from 0.2 to 3.0% FCS the growth response was linear (Fig. 1)
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FIGURE 1
￿
Effect of FCS on 31A-F2 cell growth. About 5 x 10° cells
were plated into each 60 x 15 mm dish containing 5 ml of serum-
free medium plus (") and minus (O) various concentrations of FCS.
The cells were incubated for 6 d, trypsinized, and counted with a
Coulter counter. Each point was done in triplicate, and standard
deviations did not exceed 10% of the mean value.
during an 8-d incubation period. We investigated theability of
the growth factors EGF, FGF, and OGF to stimulate cell
growth in the presence and absence of FCS. Cells were sepa-
rately incubated with various concentrations of the growth
factors in serum-free medium for 6 d. EGF consistently gave
a 100-200% increase in cell numbers vs. cells incubated in
serum-free medium alone (Fig. 2). A peak response was ob-
served at -2 ng/ml EGF with the half-maximal response
occurring at 0.8 ng/ml (1 .2 x 10-t° M). The response of 31A-
F2 cells to insulin was also determined and it was found that
cell growth was stimulated 100-150% above the serum-free
control at 1.0 pg/ml (Fig. 2). The half-maximal growth re-
sponse was achieved with 0.6 [tg/ml (1 .1 x 10-7 M) insulin
addition. The stimulation of 31A-F2 cell growth by EGF or
insulin addition alone in serum-free medium was roughly
comparable to that obtained on theaddition of 0.05-0.1% FCS
to serum-free medium (Fig. 1).
As previously reported, OGF alone did not enhance the
growth of 31A-F2 cells in serum-free medium. It did, however,
enhance cell survival and has been classified as a survival
factor for these cells (15). An examination as to whether OGF
could interact with components present in FCS to further
enhance FCS stimulation of growth was also studied. The
addition of OGF at 25 ng/ml to an FCS gradient of 0.025-
0.30% resulted in an increase in cell numbers relative to cells
incubated in FCS alone. OGF stimulated a 68-100% increase
in cell numbers when added to 0.025-0.1% FCS (Fig. 3),
indicating that OGF can play some secondary role as agrowth
cofactor. The interaction of other growth factors with compo-
nents present in FCS was also studied (Fig. 4). FGF behaved
much like OGF, butwassomewhat less consistent in enhancing
31A-F2 cell survival in serum-free medium. When FGF was
incubated with a limiting amount (0.2%) of FCS, the increase
in cell numbers obtained (60%) was nearly identical to that
obtained in the presence of similar concentrations ofOGF and
FCS. EGF addition alone, on the other hand, increased cell
numbers 150-200% over those of the serum-free control. In the
presence of 0.2% FCS, EGF stimulated a 120% enhancementó
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FIGURE 2
￿
Effect of EGF and insulin on 31A-F2 cell growth in serum-
free medium. The experimental procedure was the same as that
outlined in Fig. 1, except that various concentrations of EGF in ng/
ml (O) or insulin in Fig/ml (") were added to the dishes. The
increase in cell numbers is given as a percentage of cells incubated
in serum-free medium alone (A) . Each point represents the mean of
six determinations from three different experiments for EGF-supple-
mented dishes and four determinations from two different experi-
ments for insulin-supplemented dishes.
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FIGURE 3
￿
Effect of OGF addition to submaximal amounts of serum
on 31A-F2 cell growth . The 31A-F2 cells were plated at 5 x 10°/60
x 15 mm dish each containing 5 ml of serum-free medium (x) or
serum-free medium plus various concentrations of FCS ("), FCS and
2.5 ng/ml OGF (O), FCS and 5.0 ng/ml OGF (A), or FCS and 25 ng/
ml OGF (") . The cells were incubated for 6 d, trypsinized, and
counted with a Coulter counter. Each point is the mean of four
determinations from two different experiments.
of cell numbers over that ofthe FCS control. Thus, evaluating
the effect of growth factors on the growth of 31A-F2 cells is
dependent on the test medium. When incubated individually
in serum-free medium with 31A-F2 cells, EGF is a mitogen,
OGF behaves as a survival factor, and FGF seems to have
little effect but is not easily differentiated from OGF. When
incubated with a limiting amount (0.2%) of FCS, all three
factors stimulated substantial increases (60-100%) in cell num-
bers over those of the FCS control. These data indicate that
some positive regulatory effect on growth occurs from the
interaction of EGF, FGF, and OGF with undefined serum
components which can regulate 3 IA-F2 cell growth.
Effect of Insulin in Defined Medium on 31A-F2
Cell Growth in the Presence and Absence of
Growth Factors
The effect of insulin alone and in combination with EGF,
FGF, and OGF on the growth of 31A-F2 cells was studied in
serum-free medium. The addition of insulin at 1 .0 jig/ml (1 .75
x l0-7 M) resulted in a 100% increase in cell numbers relative
to the serum-free control after a 7-d incubation (Fig. 5). The
addition of FGF and OGF at 2.5 ng/ml increased cell numbers
-35 and 65%, respectively. When the same concentrations of
either FGF or OGF and insulin were added together, the net
increase in cell numbers (140%) was about the same as that
obtained with a single addition of EGF (150%) at 2.5 ng/ml in
serum-free medium. The co-incubation of insulin plus EGF
with the cells stimulated a slight increase in cell numbers
(170%) above that obtained with EGF alone (150%). The co-
incubation of EGF, FGF, OGF and insulin with 31A-F2 cells
resulted in a 246% increase in cell numbers above that of the
serum-free control. The same effect on growth (^-250% in-
crease) was obtained with EGF, OGF, and insulin (data not
shown). Therefore, the addition of FGF was omitted in all
subsequent experiments.
Modulatory Effect of Transferrin on 31A-F 2 Cell
Growth
Various factors (e.g., prostaglandin Fen and E,, dexametha-
sone, triiodothyronine, gonadotropin release hormone, thyro-
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FIGURE 4 Effect of EGF, FGF, OGF, and serum on 31A-F2 cell
growth. The experimental procedure was the same as that outlined
in Fig. 3, except that cells were counted daily and incubated in
serum-free medium (SFM) without (A) or with 2.5 ng/ml FGF ("),
2.5 ng/ml OGF (O, 2.5 ng/ml EGF ("), 0.2% FCS (x), 2.5 ng/ml EGF
and 0.2% FCS (O), 2.5 ng/ml FGF and 0.2% FCS (0), or 2.5 ng/ml
OGF and 0.2% FCS ("). Each point represents the mean of at least
four determinations from two different experiments.
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FIGURE 5
￿
Effect of various combinations of EGF, FGF, insulin, and
OGF on 31A-F2 cell growth. The experimental procedure was the
same as that outlined in Fig. 3, except that cells were counted daily
and incubated in serum-free medium (SFM) without (O) or with 2.5
ng/ml EGF (x), 2.5 ng/ml FGF ("), 1 Frg/ml insulin (L), 2.5 ng/ml
OGF (A), 1 FLg/ml insulin and 2.5 ng/ml EGF (O), 1 leg/ml insulin
and 2.5 ng/ml FGF (C), 1 jLg/ml insulin and 2.5 ng/ml OGF ("), or
2.5 ng/ml each of EGF, FGF, OGF and 1 fLg/ml insulin (0) . Each
point represents the mean of four determinations from two different
experiments.
tropin release hormone, follicle-stimulating hormone, transfer-
rin) were assayed for their ability to further augment the
mitogenic effect of EGF, OGF, and insulin on 31A-F2 cells in
serum-free medium. It was found that, of those assayed, trans-
ferrin mimicked a growth cofactor in its effect. While the
addition of transferrin alone to serum-free medium had no
effect on cell growth or cell survival (Fig. 6, closed circles), it
did enhance cell numbers when added with the mitogenic
mixture (EGF, OGF, and insulin). To 2.5 ng/ml each of EGF
and OGF and 1 Irg/ml insulin were added various concentra-
tions (0.01-10 pg/ml) of transferrin. After 6 d, the maximal
response to transferrin was observed at 1 ftg/ml (Fig. 7).
Transferrin added at 1 ttg/ml along with EGF, OGF, and
insulin stimulated cell numbers about twofold above those of
cells grown in the absence of transferrin (Fig. 7). The effect of
the combined factors (EGF, OGF, insulin, andtransferrin) was
approximately equal to that of -5% FCS (Fig. l). After one
medium change (arrow, Fig. 6), the cells incubated in the
presence of EGF, OGF, insulin, and transferrin reached con-
fluence on day 12.
Effect of Growth Factors and Insulin on 31A-F2
Cell Steroid Levels
In a recent communication it has been shown that 31 A-F2
cells synthesize and secrete low levels of the sex steroids
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FIGURE 6 Growth of 31A-F2 cells in defined medium plus mito-
genic factors. The experimental procedure was the same as that
outlined in Fig. 3, except that cells were incubated in serum-free
medium without (O) or with 1 tLg/ml of transferrin ("), 2.5 ng/ml
each of EGF and OGF and 1 Wg/ml of insulin (A) or 2 .5 ng/ml each
of EGF and OGF and 1 gg/ml each of insulin and transferrin (A) .
The arrow indicates that the medium was changed in all remaining
dishes and cell counts were taken on days 9 and 12. Each point is
the mean of four determinations from two different experiments.
0 1 ,.-
￿
I
0 0.01
￿
0.1
￿
1 .0
￿
10.0
Transferrin (yg/ml)
7 Dose response of transferrin augmentation of EGF, in-
sulin, and OGF stimulation of 31A-F2 cell growth . Cells were plated
at about 5 x 10"/60 x 15 mm dish each containing 5 ml of serum
free medium plus 2.5 ng/ml each of EGF and OGF and 1 f`g/ml of
insulin (") or the same concentration of EGF, OGF, and insulin with
various concentrations of transferrin (O) . The cells were incubated
for 6 d, trypsinized, and counted . Each point represents the mean of
four determinations from two experiments .(progesterone, testosterone, and estradiol-l7ß) while main-
tained in serum-free medium .' We evaluated the effects of
EGF, OGF, and insulin on total cell cholesterol and proges-
terone secretion under conditions similar to those in which
growth were defined .
Neither of themitogens(EGF and insulin) active on 31A-F2
cells has any significant effect on total cell cholesterol levels .
On the other hand, the addition of 2.5 ng/ml of OGF stimu-
lated an increase of-250% over that of controls (Fig . 8) . FGF
had virtually no effect on thegrowth or survival of 31 A-F2 cells
(Figs . 4 and 5) but stimulated an increase in cell cholesterol of
365% over that ofcontrol cultures . WhileEGFor insulin alone
had no effect, when incubated together they increased the total
cell cholesterol 320% over that of controls . The addition of
OGFand/or transferrin didnot further increase cell cholesterol
levels . Neither the catecholamine epinephrine or the cyclic
nucleotides (Bu) 2cAMP and (Bu) 2cGMP had any significant
effect on cell cholesterol levels.
The effect of the same factors on progesterone secretion from
31A-F2 cells into the culture medium was somewhat different.
Progesterone levels in the medium of cells incubated in the
presence ofOGF were not significantly different from those of
control cultures (Fig . 9) . The addition ofEGF to the cultures
produced a small (25%) but significant increase in progesterone
secretion (Fig. 9) . Insulin addition had the most dramatic effect
in increasing the progesterone secretion 116% over that of
control cultures . Thus, both of the mitogens stimulated proges-
terone secretion but not net cholesterol production . The co-
incubation of insulin with other factors (EGF, OGF, and
transferrin) seemingly reversed insulin's effect some 80-300%
below the progesterone values obtained with insulin alone . In
contrast, OGF alone had no effect on progesterone secretion,
whereas it stimulated cell cholesterol levels 250% (Fig . 8) . Thus,
the mitogens (EGF and insulin) were effective in stimulating
progesterone secretionfrom 31A-F2 cells, buthadno significant
effect on cell cholesterol levels. The growth cofactor OGF
acted in an opposite manner. OGF had no effect on progester-
one secretion, but was highly effective in stimulating cell
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FIGURE 8
￿
Effect of growth factors on 31A-F2 cell cholesterol levels .
Cells were plated at about 4 x 108/75-cm2 flask each containing 20
ml of serum-free (SF) medium plus or minus 2.5 ng/ml EGF, 2.5 ng/
ml FGF, 1 Ilg/ml insulin (INS), 2.5 ng/ml OGF, 1 Fig/ml transferrin
(TFN), 5.46 ftM epinephrine (EPI), 2 JAM (Bu) 2cAMP (DBcAMP) or
2 .4 fLM (Bu) 2CGMP (DBcGMP) . The cells were incubated for 8 d and
the cells and medium were removed and separately extracted . Each
treatment was done in triplicate, and samples were assayed in
triplicate and values are expressed as the mean ± SE .
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FIGURE 9
￿
Effect of growth factors on progesterone secretion from
31A-F2 cells . Samples of extracted medium obtained in Fig . 8 were
assayed by radioimmunoassay for progesterone. Each sample was
assayed in triplicate and values are expressed as the mean ± SE .
cholesterol concentrations. FGF was clearly different in that it
stimulated a 79% increase in progesterone secretion (Fig. 9)
and also maximallystimulated cell cholesterol levels relative to
those of controls (Fig . 8) . The effect ofother nonpeptide factors
([BU]2cAMP and epinephrine) on progesterone secretion was
also tested . Epinephrine and (Bu)2cAMP increased the concen-
tration ofprogesterone in themedium 72 and46%, respectively,
while (Bu)2cGMP hadno significant effect. In contrast, neither
of the three chemicals had any effect on cell cholesterol levels
(Fig . 8) .
DISCUSSION
+=significant at 0 05 level
or less (student's f test)
Control of ovarian cell functions represents a very complex
and intriguing regulatory pattern of cellular growth and steroid
production . The development of tissue culture has permitted
investigators to use primary cultures of granulosa and luteal
cells (6, 7) to study the factors that regulate ovarian growth,
while primary (4) and hybrid (17) granulosa cells have been
used to study the luteinization process (3) . In recent studies
from our laboratory, it has been shown that a cultured rat
ovarian subline (31A-F2) has been isolated that can be main-
tained in the absence of total serum addition to the medium
(15, 16) . These cells have been shown to be capable of synthe-
sizing and secreting the sex steroids progesterone, testosterone,
and estradiol-l7ß when maintained in serum-free medium .'
Thus, the 31A-F2 system is the first permanently established
ovarian cultured cell system that is steroidogenic . The present
study summarizes data that demonstrate that growth and ste-
roid production in 31A-F2 cells are regulated by specific growth
factors and hormones under defined culture conditions .
The growth factors OGF and FGF did not behave like
mitogens for 31A-F2 cells . Instead, OGF was a survival and
growth cofactor (Figs . 5 and 6 and reference 15) . However,
EGF and insulin, singly, did stimulate cell growth (Fig . 2) and
were, therefore, considered to be mitogenic. A combination of
insulin plus EGF and other factors further increased cell
growth. The inclusion of OGF and transferrin with EGF and
insulin (Fig. 6) increased cell numbers by 1,570% over those of
the serum-free control. In this system, transferrin is not a
primary mitogen (such as EGF and insulin) but acts as a
cofactor, i.e ., it enhances the effect ofEGF and insulin but has
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487no effect when incubated with 31A-F2 cells by itself. The
combination of EGF, OGF, insulin, and transferrin was ap-
proximately equal to ^-5% FCS addition when assayed in 7- to
8-d growth experiments.
It has been reported that the growth of primary cultures of
granulosa cellsis stimulated by EGF and FGF, while luteinized
granulosa cells (luteal cells) respond only to FGF (6, 7). The
31A-F2 cells respond to EGF but not to FGF. It would be of
interest to see if primary cultures of thecal cells respond only
to EGF. No augmentative effect of dexamethasone on growth
was observed when 31A-F2 cells were incubated alone or in
combination with EGF, OGF, insulin, and/or transferrin (J.
H. Wyche, unpublished data). It had been previously reported
for the 31 Aparent cell line that dexamethasone stimulated cell
growth (5). While the iron-binding protein transferrin aug-
mented EGF-mediated growth 2- to 2.5-fold, it does not alter
1251-EGF binding to 31A-F2 cells in the presence or absence of
OGF and insulin.' Dexamethasone, on the other hand, has
been shown to modulate EGF binding to cultured human
fibroblast (1).
Insulin has been implicated in playing a role in granulosa
cell survival and augmenting progestin secretion when these
cells were maintained fora fewdays in serum-free medium (4).
In addition to affecting growth, insulin was found to have a
stimulatory effect on the secretion of progesterone from 31A-
F2 cells (Fig. 9). Insulin did not have a generalized effect
because cellular cholesterol (Fig. 8) levels were notsignificantly
affected. Thus, it may be postulated that insulin may also have
a specific role in regulating progestin secretion and possibly its
synthesis in 31A-F2 rat ovarian cells. The effect of a combina-
tion ofhormones andgrowth factors on cholesterol biosynthesis
in 31A-F2 cells represents a generalized induction of one or
more rate-limiting steps (e.g., 20a-hydroxycholesterol) in the
sterol biosynthetic conversion of cholesterol to the sex steroids.
While insulin seems to increase progesterone secretion from
31A-F2 cells, its effect is lost when EGF is added. The data
suggest that EGF and insulin act synergistically on 31A-F2cell
growth but not on progesterone production. The addition of
OGF and transferrin to EGF and insulin further inhibited
progesterone secretion below control levels (Fig. 9). This could
represent a shunting of the important cell cholesterol pool into
membrane components that are under heavier demand when
cell division becomes more important than cell differentiation
(i.e., progesterone production). Such may be the case when
31A-F2 cell division is maximally stimulated in serum-free
medium by the mitogenic mixture of EGF, insulin, OGF, and
transferrin (Fig. 6). It is not possible to explain at present the
significant stimulation in cell cholesterol by OGF and FGF
(Fig. 8) and in progesterone secretion by FGF (Fig. 9). It may
be that the site(s) of action for OGF and FGF on 31A-F2 cells
may differ from that of EGF, insulin, and possibly transferrin.
We postulated that the predominant or primary metabolic
effect of FGF and OGF may be at some other site (e.g.,
mitochondria) involving cholesterol conversion perhaps anal-
ogous to the effect that adrenocorticotropic hormone has on
cholesterol conversion in adrenalcells (11). Whatever themode
ofaction, (Bu)2cAMP and (Bu)2cGMP were incapable of mim-
icking the stimulatory effect of growth factors on cell choles-
terol, which suggests that the effect may not be mediated
' Turner, J. T., and J. H. Wyche. 1979. Regulationof metastatic ovarian
cells in serum-free medium by epidermalgrowth factor andtransferrin.
Manuscript submitted for publication.
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through a membrane-associated adenylate or guanylate cy-
clase.
It has been reported that catecholamines (e.g., epinephrine)
activate adenylate cyclase which is involved in mediating the
response of hormones on progesterone production in luteal
cells (10). While epinephrine and (Bu)2CAMP had no effect on
31A-F2 cell growth (J. Wyche, unpublished data), both did
significantly enhance progesterone secretion (Fig. 10). This
seems to be a selective event because cell cholesterol levels
were not significantly affected. Also, (Bu)2cGMP had no effect
on either cell cholesterol or progesterone production in 31A-F2
cells, suggesting that the adenylate cyclase system may be
specifically involved in progesterone secretion. Thus,there may
be two modes ofhormone action involved in steroid formation
in 31A-F2 cells. The synthesis and conversion of cholesterol
takes place presumably at the mitochondria. It is at this site
that the nonmitogenic growth cofactors (FGF and OGF) may
have their primary regulatory effect (cAMP-independent ac-
tion). Substances whose primary effect is elicited by some
association with cell membrane components (e.g., adenylate
cyclase) may have little effect on mitochondrial cholesterol
metabolism in 31A-F2 cells. Therefore, it is proposed that EGF,
insulin, epinephrine and (Bu)2CAMP may directly stimulate
the adenylate cyclase activity (cAMP-dependent action) asso-
ciated with the cell membrane, resulting in enhanced proges-
terone secretion in 31A-F2 cells.
In summary, the data presented in this communication and
elsewhere (footnote 2 and reference 15) have shown that 3IA-
F2 rat cultured cells are the first permanently established
ovarian system. These cells can be maintained in completely
defined medium and their growth can be regulated by the
addition of a protein growth factor (EGF), a peptide hormone
(insulin), and a serum-binding protein (transferrin). Under
specific culture conditions the differentiated status of the cells
can be regulated. Progesterone secretion can be regulated by
insulin, (Bu)2cAMP, epinephrine, FGF, and possibly EGF.
While 31A-F2 is a hormonally responsive ovarian system, it
does not possess all the functional characteristics (e.g., loss of
gonadotropin receptors') of normal ovarian cells. However, it
does maintain some properties relevant to the problems of
ovarian growth and steroid function that can be studied in
vitro under defined culture conditions.
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National Science Foundation.
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